The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ORIC FINANCIAL STATEMENTS

Oric Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ORICOric Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-320 K $ · -Infinity%Operating Income-156.1 M $ · -Infinity%Pre-tax Income-140.4 M $ · -Infinity%Net Income to Owners-140.4 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-320 K $—
Operating Income-156.1 M $—
EBITDA-143.3 M $—
Net Income to Owners-140.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets404.7 M
  • Equity381.3 M $94%
  • Current Liabilities20.8 M $5%
  • Long-term Liabilities2.7 M $1%

Key Figures

YoY change
Total Assets404.7 M $+16.7%
Total Liabilities23.4 M $+2.5%
Total Equity381.3 M $+17.7%
Cash & ST Investments264.8 M $-6.3%
Total Debt——
Net Debt-37.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-111.6 M $Operating-99.7 M $Investing172.9 M $Financing-38.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow-111.6 M $—
Capital Expenditures426 K $-60.8%
Free Cash Flow-112.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ORIC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.